Apollo Hospitals Enterprise Ltd (APOLLOHOSP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Apollo Hospitals Enterprise Ltd (APOLLOHOSP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9948
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apollo Hospitals Enterprise Ltd (Apollo Hospitals) is a healthcare service provider. It offers healthcare services, clinical and diagnostic services, medical business process outsourcing, third party administration services and health insurance. The company also provides services to support business, telemedicine services, education, training programs and research services and other non-profit projects. Apollo Hospitals specializes in cardiology, orthopedics, spine, cancer care, gastroenterology, neurosciences, nephrology and urology, critical care and preventive health care. Apart from India, it has presence through hospitals in Dhaka, Mauritius and the UK. Apollo Hospitals is headquartered in Chennai, Tamil Nadu, India.

Apollo Hospitals Enterprise Ltd (APOLLOHOSP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Apollo Hospitals Enterprise Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Apollo Hospitals Plans to Acquire Healthcare Facility 13
Apollo Hospitals Rumored To Acquire Lifeline Multi Speciality Hospital From Lifeline Group Of Hospitals 14
Private Equity 15
Apax Partners Sells Stake In Apollo Hospitals For US$23 Million 15
OppenheimerFunds Acquires 4.6% Stake In Apollo Hospitals From Apax Partners For US$98 Million 16
CLSA Mauritius Sells 6.15% Stake In Apollo Hospitals For US$127 Million 17
Partnerships 18
Apollo Hospitals Plans to Form Joint Venture with Sanofi 18
Apollo Hospital Forms Joint Venture With Saarum Innovations 19
Apollo Hospitals To Form Joint Venture With Parkway Holdings 20
Debt Offering 21
Apollo Hospitals Announces Private Placement Of Debentures Due 2018 For US$81.4 Million 21
Apollo Hospitals Enterprise Plans Public Offering Of Corporate Bonds For US$22 Million 22
Acquisition 23
Apollo Hospitals Enterprise May Acquire 50% Stake in Apollo Gleneagles Hospitals from Parkway Pantai 23
Apollo Hospitals Acquires 51% stake in Assam Hospitals for USD9 Million 24
Sanofi-Synthelabo Acquires 20% Stake in Apollo Sugar Clinics for USD14.6 Million 25
Apollo Hospital Acquires Nova Specialty Hospitals 26
Netcare and Reliance Foundation May Acquire Sevenhills Healthcare 27
IHH Healthcare Plans To Sell 10.8% Stake In Apollo Hospitals 29
Nova Specialty Surgery Acquires Majority Stake In Excel Hospitals 30
Apollo Hospitals Enterprise To Acquire Remaining 10% Stake In Imperial Hospital and Research Centre For US$18 Million 31
Apollo Hospitals Enterprise Acquires Additional 39% Stake In Imperial Hospital and Research Centre For US$17.4 Million 32
Apollo Hospitals Enterprise Ltd – Key Competitors 33
Apollo Hospitals Enterprise Ltd – Key Employees 34
Apollo Hospitals Enterprise Ltd – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Joint Venture 37
Recent Developments 39
Strategy And Business Planning 39
Oct 03, 2018: Apollo Cradle, Hyderabad launched Pediatric Intensive Care Unit (PICU) with round-the-clock multi-disciplinary care. 39
Sep 14, 2018: India’s Apollo Hospitals to add 765 beds over five years 40
Other Significant Developments 41
Jul 27, 2018: Apollo Hospitals, Chennai successfully performed a rare Quadruple joint replacement surgery on a Bangladeshi patient, which enabled him to walk after more than four years 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Apollo Hospitals Enterprise Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Apollo Hospitals Enterprise Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Apollo Hospitals Plans to Acquire Healthcare Facility 13
Apollo Hospitals Rumored To Acquire Lifeline Multi Speciality Hospital From Lifeline Group Of Hospitals 14
Apax Partners Sells Stake In Apollo Hospitals For US$23 Million 15
OppenheimerFunds Acquires 4.6% Stake In Apollo Hospitals From Apax Partners For US$98 Million 16
CLSA Mauritius Sells 6.15% Stake In Apollo Hospitals For US$127 Million 17
Apollo Hospitals Plans to Form Joint Venture with Sanofi 18
Apollo Hospital Forms Joint Venture With Saarum Innovations 19
Apollo Hospitals To Form Joint Venture With Parkway Holdings 20
Apollo Hospitals Announces Private Placement Of Debentures Due 2018 For US$81.4 Million 21
Apollo Hospitals Enterprise Plans Public Offering Of Corporate Bonds For US$22 Million 22
Apollo Hospitals Enterprise May Acquire 50% Stake in Apollo Gleneagles Hospitals from Parkway Pantai 23
Apollo Hospitals Acquires 51% stake in Assam Hospitals for USD9 Million 24
Sanofi-Synthelabo Acquires 20% Stake in Apollo Sugar Clinics for USD14.6 Million 25
Apollo Hospital Acquires Nova Specialty Hospitals 26
Netcare and Reliance Foundation May Acquire Sevenhills Healthcare 27
IHH Healthcare Plans To Sell 10.8% Stake In Apollo Hospitals 29
Nova Specialty Surgery Acquires Majority Stake In Excel Hospitals 30
Apollo Hospitals Enterprise To Acquire Remaining 10% Stake In Imperial Hospital and Research Centre For US$18 Million 31
Apollo Hospitals Enterprise Acquires Additional 39% Stake In Imperial Hospital and Research Centre For US$17.4 Million 32
Apollo Hospitals Enterprise Ltd, Key Competitors 33
Apollo Hospitals Enterprise Ltd, Key Employees 34
Apollo Hospitals Enterprise Ltd, Other Locations 35
Apollo Hospitals Enterprise Ltd, Subsidiaries 36
Apollo Hospitals Enterprise Ltd, Joint Venture 37

List of Figures
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Apollo Hospitals Enterprise Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Apollo Hospitals Enterprise Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Apollo Hospitals Enterprise Ltd (APOLLOHOSP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sartorius AG (SRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • Coats Group plc:企業の戦略・SWOT・財務情報
    Coats Group plc - Strategy, SWOT and Corporate Finance Report Summary Coats Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Norwegian Air Shuttle ASA:企業の戦略・SWOT・財務分析
    Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report Summary Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Modine Manufacturing Company:企業の戦略・SWOT・財務情報
    Modine Manufacturing Company - Strategy, SWOT and Corporate Finance Report Summary Modine Manufacturing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SoftBank Group Corp (9984):企業の財務・戦略的SWOT分析
    SoftBank Group Corp (9984) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lion Corporation:企業の戦略・SWOT・財務情報
    Lion Corporation - Strategy, SWOT and Corporate Finance Report Summary Lion Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • NeuroSearch AS (NEUR)-製薬・医療分野:企業M&A・提携分析
    Summary NeuroSearch A/S (NeuroSearch) focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system (CNS) through license agreements with other life science companies. The company divested all rights of Huntexil for the treatment of patien …
  • Novanta Inc (NOVT):医療機器:M&Aディール及び事業提携情報
    Summary Novanta Inc (Novanta), formerly GSI Group Inc is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam de …
  • Sanofi India Ltd (SANOFI):企業の財務・戦略的SWOT分析
    Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company. It manufactures and markets pharmaceutical and prescription products. The company offers products in the form of capsules, tablets, injection, vials, ampoules, ointments, creams and …
  • Highmark Inc.:企業の戦略・SWOT・財務情報
    Highmark Inc. - Strategy, SWOT and Corporate Finance Report Summary Highmark Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Trevena Inc (TRVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • MRC Global Inc (MRC)-石油・ガス分野:企業M&A・提携分析
    Summary MRC Global Inc (MRC) is a provider of pipe, valves and fittings. Its product portfolio include carbon steel pipe, carbon steel fittings and flanges, valve automation, stainless and alloy pipe, stainless and alloy fittings and flanges, industrial products, specialty products, oilfield product …
  • Accredo Health Group Inc:企業の戦略的SWOT分析
    Accredo Health Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Weatherford International Plc (WFT):石油・ガス:M&Aディール及び事業提携情報
    Summary Weatherford International Plc (Weatherford) is an oilfield service provider. The company offers equipment and services utilized in the drilling, evaluation, completion, production and intervention of oil and natural gas wells. Its product line includes artificial lift systems, completion sys …
  • Ferguson Plc:企業の戦略・SWOT・財務分析
    Ferguson Plc - Strategy, SWOT and Corporate Finance Report Summary Ferguson Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Helena Laboratories Corp:企業の製品パイプライン分析2018
    Summary Helena Laboratories Corp (Helena) is a medical device company that provides clinical laboratory instruments. The company offers electrophoresis analyzers, densitometers, electrophoresis supplies, hemostasis instruments, spife replacement pump, immunology and protein diagnostic products. It o …
  • ProAxsis Ltd:企業の製品パイプライン分析2018
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • Martin Marietta Materials, Inc.:戦略・SWOT・企業財務分析
    Martin Marietta Materials, Inc. - Strategy, SWOT and Corporate Finance Report Summary Martin Marietta Materials, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Alnylam Pharmaceuticals Inc (ALNY)-医療機器分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆